Isaac Manke, Public Investment Director, joined New Leaf Venture Partners in 2009. Prior to joining New Leaf, Isaac was an Associate in the Global Biotechnology Equity Research group at Sanford C. Bernstein. Previously, Isaac worked as an Associate in the Biotechnology Equity Research group at Deutsche Bank. Prior to joining Deutsche Bank, Isaac was a Senior Analyst at Health Advances, a biopharmaceutical and medical device strategy consulting firm in Massachusetts. Isaac received a B.A. in Biology and a B.A. in Chemistry at Minnesota State University (Moorhead), and a Ph.D. in Biophysical Chemistry and Molecular Structure at the Massachusetts Institute of Technology (MIT).

Isaac’s discoveries led to several publications in top journals, including Science and Cell, and were selected by Science as one of the “2003: Signaling Breakthroughs of the Year”. These discoveries also resulted in four issued patents. While at MIT, Isaac also completed several business classes at the Sloan School of Management.